Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc. Scilex Holding Company (Nasdaq: SCLX) confirmed a Dream Bowl 2026 Meme Coin claim process tied to a December 24, 2025 distribution. Eligible shareholders of record as of November 25, 2025 may claim allocated tokens any time after the December 24, 2025 distribution using the designated process at www.dreambowlcoin.com. The token program is powered by Datavault AI using encrypted blockchain infrastructure and real-world asset tokenization. The announcement positions the meme coin as a fusion of sports, digital assets, and shareholder perks. For corporate and product information, Scilex directs investors to its corporate and product websites.

#SCLX #SCLXW Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds Scilex Holding Company (Nasdaq: SCLX) announced a definitive agreement for the cash exercise of existing warrants to purchase an aggregate of 904,396 shares of common stock, generating approximately $20.3 million in gross proceeds before placement agent fees and offering expenses.In exchange for immediate cash exercise, the company will issue a new unregistered warrant to purchase up to 1,356,594 shares at an exercise price of $29.00 per share, exercisable immediately with a five-year term. The offering is expected to close on or about November 25, 2025, and net proceeds are planned for working capital and general corporate purposes.

#SCLX #SCLXW Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Holding Company Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin by Datavault AI Inc. Scilex Holding Company (Nasdaq: SCLX) said Datavault AI (Nasdaq: DVLT) intends to voluntarily distribute Dream Bowl 2026 Meme Coins to Scilex record holders as of November 25, 2025, concurrent with Datavault AI's own eligible holders.Nasdaq told Datavault AI it will not make an announcement for Scilex about the distribution date. Distribution is conditional on recipients opting in, setting up a Data Vault® wallet, and providing documentation. Datavault AI's board may change the record date and will set the payment date within 60 days after the record date; payment is conditioned on the board not revoking the distribution.

#SCLX #SCLXW Scilex Holding Company Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin by Datavault AI Inc.

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI Scilex Holding Company (Nasdaq: SCLX) has announced a strategic $150 million Bitcoin investment in Datavault AI Inc. (Nasdaq: DVLT). The investment will provide Datavault with growth capital to enhance its supercomputing infrastructure and expand data exchanges.Under the agreement, Scilex will receive up to 278,914,094 shares of Datavault common stock at an effective price of $0.5378 per share. The transaction will occur in two tranches, with 15 million shares issued at initial closing and the remainder through a pre-funded warrant pending stockholder approval.The partnership aims to capitalize on the growing biotech data monetization market, projected to reach $30-50 billion by 2024. Scilex will gain board representation rights, with the ability to nominate two directors while maintaining 10% ownership or one director at 5-10% ownership.

#SCLX #SCLXW Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI

www.stocktitan.net/news/SCLX/scilex-holding...

Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal Scilex Holding Company (SCLX) announced a publication highlighting GLOPERBA's dosing adjustments in a peer-reviewed journal. GLOPERBA is the first liquid oral colchicine for gout flare prophylaxis, enabling precision dosing for patients with renal impairment. The study reveals that patients with renal issues taking standard colchicine formulations often receive sub-optimal or excessive doses. The research demonstrates that GLOPERBA's liquid format allows for more precise dosing: 0.48 mg for moderate renal impairment and 0.3 mg for severe renal impairment, leading to better therapeutic outcomes. This is particularly significant as over 70% of gout patients have comorbid conditions requiring dose adjustments.

#SCLX #SCLXW Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal

www.stocktitan.net/news/SCLX/scilex-holding...